Skip to content Skip to footer

Visby Medical Reports the US FDA Clearance and CLIA Waiver for Point-of-Care Respiratory Health Test

Shots:

  • The US FDA granted 510(k) clearance (previously granted with EUA in Dec’22) and CLIA waiver for point-of-care respiratory health test. The Visby Medical Respiratory Health
  • Test is a rapid PCR test used to detect and differentiate between upper respiratory infections caused by influenza (Flu) A & B and SARS-CoV-2 (COVID-19)
  • Under the contract number 75A50121C0, the project has received complete or partial funding from federal sources provided by the Department of Health and Human Services, specifically through the Administration for Strategic Preparedness and Response and BARDA
  • Furthermore, the studies funded by BARDA are ongoing to explore more features to support at-home respiratory test

Ref: Prnewswire | Image: Visby Medical

Related News:- ABANZA Reports the US FDA 510(k) Clearance of WasherCap Mini for Orthopedic Surgeries

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]